Single Ascending Dose and Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-1816 in Healthy Subjects
Clinical trial NCT05330208 · TERMINATED
Trial details
- NCT number
- NCT05330208
- Sponsor
- Beijing Suncadia Pharmaceuticals Co., Ltd
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-18
- Primary completion
- 2022-09-05
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.